These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5422191)

  • 21. Cancer and leukemia group B breast committee: decades of progress and plans for the future.
    Hudis CA; Winer EP
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3576s-80s. PubMed ID: 16740788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A ray of hope for leukemia and neoplasms].
    Kurz JF
    Z Allgemeinmed; 1969 May; 45(13):627-9. PubMed ID: 5801655
    [No Abstract]   [Full Text] [Related]  

  • 23. [Monitoring anticancerous and antileukemic chemotherapy in children].
    Cramer P; Schaison G
    Sem Hop; 1983 Mar; 59(11):769-73. PubMed ID: 6304903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytostatic chemotherapy in the treatment of malignant tumors].
    Langhammer H; Klemm J; Pabst HW
    Arztl Forsch; 1966 Aug; 20(8):393-403. PubMed ID: 6014703
    [No Abstract]   [Full Text] [Related]  

  • 25. [Interferon in antitumoral chemotherapy].
    Soria M
    Recenti Prog Med; 1981 May; 70(5):494-523. PubMed ID: 6171850
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in thyroid hormone state in children receiving chemotherapy.
    van Santen HM; Thonissen NM; de Kraker J; Vulsma T
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):250-7. PubMed ID: 15670204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neocarzinostatin in cancer chemotherapy (review).
    Maeda H
    Anticancer Res; 1981; 1(3):175-86. PubMed ID: 6211130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug induced white blood cells injury (antimitotic chemotherapy) and other drugs].
    Rumilly F; Witz F; Eisenmann JC; Lederlin P; Herbeuval R
    Therapie; 1982; 37(4):371-5. PubMed ID: 7135316
    [No Abstract]   [Full Text] [Related]  

  • 29. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Perspectives of neoplasm chemotherapy].
    Schmähl D
    Geburtshilfe Frauenheilkd; 1970 Jan; 30(1):13-24. PubMed ID: 5462035
    [No Abstract]   [Full Text] [Related]  

  • 31. Myeloprotective effect of a non-toxic indigenous preparation Rasayana in cancer patients receiving chemotherapy and radiation therapy. A pilot study.
    Joseph CD; Praveenkumar V; Kuttan G; Kuttan R
    J Exp Clin Cancer Res; 1999 Sep; 18(3):325-9. PubMed ID: 10606177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dosage regimen optimization in cancer chemotherapy using a mathematical model].
    Barbolosi D; Freyer G; Ciccolini J; Iliadis A
    Bull Cancer; 2003 Feb; 90(2):167-75. PubMed ID: 12660135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
    Shi YK; Zhou JC; Feng FY
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):207-10. PubMed ID: 7525173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the serum lysozyme level as a further parameter for predicting hematological tolerance in patients treated with cytostatic chemotherapy. Study of 134 cases].
    Neretto G; Agricola R; Giovanelli E; Poccardi G; Pellerito R; Furno F; Martinetto P; Pellegrino S; Daglio C; Tondolo M
    Recenti Prog Med; 1980 Oct; 69(4):431-57. PubMed ID: 7006015
    [No Abstract]   [Full Text] [Related]  

  • 36. Cancer in the aged.
    Holland JF
    Mt Sinai J Med; 1981; 48(6):496-9. PubMed ID: 6977706
    [No Abstract]   [Full Text] [Related]  

  • 37. [Special topic issue: hematology/oncology].
    Hiddemann W
    Dtsch Med Wochenschr; 2002 Mar; 127(9):429. PubMed ID: 11870556
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of in vitro lymphocyte transformation during chemotherapy in man.
    Hersh EM; Oppenheim JJ
    Cancer Res; 1967 Jan; 27(1):98-105. PubMed ID: 6020370
    [No Abstract]   [Full Text] [Related]  

  • 39. [Secondary leukemia following chemotherapy of various malignancies].
    Abe T; Tsuda S; Takino T
    Gan No Rinsho; 1984 Sep; 30(12 Suppl):1543-52. PubMed ID: 6513006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy-induced leukemia -- an underestimated complication of antineoplastic chemotherapy?].
    Dührsen U
    Zentralbl Gynakol; 2005 Aug; 127(4):235-41. PubMed ID: 16037905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.